News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agenus (AGEN) Prices Public Offering Of Common Stock


2/5/2014 8:38:47 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) today announced the pricing of an underwritten public offering of 19,335,653 primary shares of its common stock at a price of $2.70 per share. Agenus has granted the underwriters a 30-day option to purchase up to 2,900,347 additional shares of common stock to cover over-allotments, if any. William Blair & Company, L.L.C. is acting as sole book-running manager for the offering. Maxim Group LLC is acting as lead manager and H.C. Wainwright & Co., LLC and MLV & Co. LLC are acting as co-managers for the offering. Geller Biopharm Inc. is acting as financial advisor for the offering.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES